BOGANI, COSTANZA
 Distribuzione geografica
Continente #
EU - Europa 2.011
NA - Nord America 1.974
AS - Asia 445
SA - Sud America 58
OC - Oceania 13
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.510
Nazione #
US - Stati Uniti d'America 1.969
PL - Polonia 1.041
RU - Federazione Russa 354
SE - Svezia 145
HK - Hong Kong 140
IE - Irlanda 128
SG - Singapore 124
IT - Italia 122
CN - Cina 86
DE - Germania 62
BR - Brasile 53
FI - Finlandia 37
IN - India 36
GB - Regno Unito 34
UA - Ucraina 28
CH - Svizzera 21
VN - Vietnam 16
FR - Francia 14
JO - Giordania 14
AU - Australia 13
BE - Belgio 9
TR - Turchia 9
ID - Indonesia 8
ES - Italia 6
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
NL - Olanda 4
CA - Canada 3
BD - Bangladesh 2
LT - Lituania 2
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 4.510
Città #
Warsaw 1.040
Santa Clara 569
Fairfield 202
Chandler 137
Dublin 128
Hong Kong 122
Ashburn 103
Woodbridge 101
Houston 89
Seattle 89
Singapore 77
Cambridge 75
Wilmington 72
Ann Arbor 59
Jacksonville 55
Beijing 44
Lawrence 33
Altamura 30
Princeton 30
Buffalo 25
Florence 22
Bern 21
Boston 20
Boardman 18
Pune 18
Bremen 15
Dong Ket 15
Mumbai 15
Munich 14
Shanghai 14
Melbourne 12
San Diego 10
Turku 10
Brussels 9
Los Angeles 9
Medford 9
Jakarta 8
Frankfurt am Main 6
Izmir 6
Phoenix 6
Salerno 6
Andover 5
New York 5
Rignano sull'Arno 5
Abidjan 4
Cagliari 4
Falls Church 4
London 4
Norwalk 4
Prato 4
São Paulo 4
West Jordan 4
Abu Dhabi 3
Basauri 3
Cavriago 3
Frankfurt Am Main 3
Hefei 3
Hillsboro 3
Kent 3
Naples 3
The Dalles 3
Amman 2
Ariano Irpino 2
Barcelona 2
Bitonto 2
Brooklyn 2
Caldiero 2
Cremona 2
Franca 2
Hangzhou 2
Hebei 2
Helsinki 2
Juiz de Fora 2
Milan 2
Montevarchi 2
Moscow 2
Redwood City 2
Roubaix 2
San Jose 2
São Gonçalo 2
Toronto 2
Treviso 2
Abaetetuba 1
Acton 1
Amsterdam 1
Anta Gorda 1
Araucária 1
Auburn Hills 1
Baghdad 1
Belo Horizonte 1
Bengaluru 1
Biloxi 1
Birigui 1
Bismarck 1
Brasília 1
Bratislava 1
Buccinasco 1
Bursa 1
Campos do Jordão 1
Canaan 1
Totale 3.477
Nome #
Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. 297
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives 284
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial 279
mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms. 277
Caratterizzazione di alterazioni molecolari relative alla patogenesi delle Neoplasie Mieloproliferative Croniche 271
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis 270
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils of polycythemia vera. 250
Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis. 248
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis. 229
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). 177
Overexpression of microRNA-16-2 contributes to the abnormalerythropoiesis in polycythemia vera. 173
MicroRNA expression profile in granulocytes from primary myelofibrosis patients. 161
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 155
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 146
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 144
Inconsistencies in the association between the JAL2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 143
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines 142
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. 142
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. 128
Preclinical models for drug selection in myeloproliferative neoplasms. 124
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 112
JAK PI3K/mTOR COMBINATION THERAPY 105
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 105
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis 98
mTOR/JAK INHIBITOR COMBINATION THERAPY 91
Totale 4.551
Categoria #
all - tutte 10.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021445 42 43 18 65 22 46 21 34 41 55 27 31
2021/2022228 7 12 31 11 9 13 5 16 8 12 47 57
2022/2023572 48 112 26 57 49 93 67 43 40 6 8 23
2023/2024203 6 20 27 18 22 58 3 31 2 2 8 6
2024/20251.432 23 139 86 193 422 256 18 92 59 20 50 74
2025/202620 20 0 0 0 0 0 0 0 0 0 0 0
Totale 4.551